Skip to main content

$0.050 (0%)

High

$0.05

Low

$0.05

Trades

132

Turnover

$407,237

Volume

8,117,500
30 June 2023 at 3:59pm
Register to track ALA and receive email alerts.
Subject
ALA Ann: Quarterly Appendix 4C and Activities Report

ALA Ann: Letter to Option Holders

ALA Ann: Initial Director's Interest Notice

ALA Ann: Appointment of Mr Gary Phillips as Non-Executive Director

ALA Ann: Final Director's Interest Notice

ALA Ann: Notification regarding unquoted securities - ALA

ALA Ann: Sumatriptan Update

ALA Ann: ZolpiMist Launch Australia

ALA Ann: Arovella Therapeutics Adopts WEF Framework For ESG Reporting

ALA Ann: Board Changes

ALA Ann: Change of Share Registry

ALA Ann: Quarterly Appendix 4C and Activities Report

ALA Ann: Services Agreement with Q-Gen for CAR19-iNKT manufacture

ALA Ann: Anagrelide patent for the United States

ALA Ann: Notice Under Section 708A

ALA Ann: Notification regarding unquoted securities - ALA

ALA Ann: Notification regarding unquoted securities - ALA

ALA Ann: Application for quotation of securities - ALA

ALA Ann: Application for quotation of securities - ALA

ALA Ann: Proposed issue of securities - ALA

ALA Ann: Change of Director's Interest Notice x5

ALA Ann: Notice Under Section 708A

ALA Ann: Application for quotation of securities - ALA

ALA Ann: Application for quotation of securities - ALA

ALA Ann: Results of General Meeting

ALA Ann: Update - Proposed issue of securities - ALA

ALA Ann: Appendix 4D and Half Year Report

ALA Ann: Arovella SPP Closed early over subscribed

ALA Ann: Notice of Extraordinary General Meeting/Proxy Form

ALA Ann: Proposed issue of securities - ALA

ALA Ann: Section 708A Disclosure Notice

ALA Ann: Application for quotation of securities - ALA

ALA Ann: Investor Presentation

ALA Ann: Becoming a substantial holder

ALA Ann: Quarterly Appendix 4C and Activities Report

ALA Ann: Update - Proposed issue of securities - ALA

ALA Ann: Arovella Appoints New Cell Therapy Development Expert

ALA Ann: Cleansing Notice - Share purchase plan

ALA Ann: Proposed issue of securities - ALA

ALA Ann: Proposed issue of securities - ALA

ALA Ann: Proposed issue of securities - ALA

ALA Ann: Proposed issue of securities - ALA

ALA Ann: SPP Offer Booklet

ALA Ann: Arovella Completes $4.57M Placement & Launches $1.5M SPP

ALA Ann: Trading Halt

ALA Ann: Final Director's Interest Notice

ALA Ann: Arovella to present at Biotech Showcase 2022

ALA Ann: Change of Director's Interest Notice x 4

ALA Ann: Notification regarding unquoted securities - ALA

ALA Ann: Results of Annual General Meeting

Register to track ALA and receive email alerts.